Skip to main content
NASDAQ:XNCR

Xencor News Headlines

$40.54
+1.99 (+5.16 %)
(As of 05/14/2021 12:00 AM ET)
Add
Compare
Today's Range
$38.25
$40.65
50-Day Range
$37.92
$44.68
52-Week Range
$27.38
$58.35
Volume260,159 shs
Average Volume227,133 shs
Market Capitalization$2.36 billion
P/E RatioN/A
Dividend YieldN/A
Beta0.8

Headlines

Xencor (NASDAQ XNCR) News Headlines Today

SourceHeadline
4 ways biotech can lead Los Angeles economic recovery (Video) - LA Biz - L.A. Biz4 ways biotech can lead Los Angeles' economic recovery (Video) - LA Biz - L.A. Biz
bizjournals.com - May 13 at 8:56 AM
Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference - Yahoo FinanceXencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference - Yahoo Finance
finance.yahoo.com - May 13 at 8:56 AM
Xencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual ConferenceXencor to Present at the 2021 RBC Capital Markets Global Healthcare Virtual Conference
finance.yahoo.com - May 12 at 7:51 PM
Minerva (NERV) Soars on Promising Schizophrenia Study Data - NasdaqMinerva (NERV) Soars on Promising Schizophrenia Study Data - Nasdaq
nasdaq.com - May 12 at 2:50 PM
How biotech can lead L.A.s post-Covid recovery — panel (Video) - L.A. Biz - L.A. BizHow biotech can lead L.A.'s post-Covid recovery — panel (Video) - L.A. Biz - L.A. Biz
bizjournals.com - May 11 at 2:10 PM
Anti-CD19 Antibody Pipeline Report, 2021 Featuring TG Therapeutics, Merck kGaA, Generium Pharmaceutical, Sanofi, Incyte Corporation, Amgen, Viela Bio, and others - Yahoo FinanceAnti-CD19 Antibody Pipeline Report, 2021 Featuring TG Therapeutics, Merck kGaA, Generium Pharmaceutical, Sanofi, Incyte Corporation, Amgen, Viela Bio, and others - Yahoo Finance
finance.yahoo.com - May 10 at 8:35 PM
SVB Leerink Weighs in on Xencor, Inc.s Q2 2021 Earnings (NASDAQ:XNCR)SVB Leerink Weighs in on Xencor, Inc.'s Q2 2021 Earnings (NASDAQ:XNCR)
americanbankingnews.com - May 10 at 1:14 AM
Q2 2021 EPS Estimates for Xencor, Inc. Increased by Wedbush (NASDAQ:XNCR)Q2 2021 EPS Estimates for Xencor, Inc. Increased by Wedbush (NASDAQ:XNCR)
americanbankingnews.com - May 10 at 1:14 AM
SVB Leerink Reaffirms "Buy" Rating for Xencor (NASDAQ:XNCR)SVB Leerink Reaffirms "Buy" Rating for Xencor (NASDAQ:XNCR)
americanbankingnews.com - May 9 at 8:02 AM
Did You Miss C.H. Robinson Worldwides (NASDAQ:CHRW) 38% Share Price Gain? - NasdaqDid You Miss C.H. Robinson Worldwide's (NASDAQ:CHRW) 38% Share Price Gain? - Nasdaq
nasdaq.com - May 8 at 8:16 PM
Xencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings Call Transcript - Seeking AlphaXencor, Inc. (XNCR) CEO Bassil Dahiyat on Q1 2021 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - May 8 at 8:16 PM
What Does The Future Hold For Home Point Capital Inc. (NASDAQ:HMPT)? These Analysts Have Been Cutting Their Estimates - NasdaqWhat Does The Future Hold For Home Point Capital Inc. (NASDAQ:HMPT)? These Analysts Have Been Cutting Their Estimates - Nasdaq
nasdaq.com - May 8 at 3:15 PM
Energy Recoverys (NASDAQ:ERII) Returns On Capital Are Heading Higher - NasdaqEnergy Recovery's (NASDAQ:ERII) Returns On Capital Are Heading Higher - Nasdaq
nasdaq.com - May 8 at 3:15 PM
Earnings Beat: Xencor, Inc. (NASDAQ:XNCR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - NasdaqEarnings Beat: Xencor, Inc. (NASDAQ:XNCR) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts - Nasdaq
nasdaq.com - May 8 at 3:15 PM
Xencor Inc (XNCR) Q1 2021 Earnings Call Transcript - The Motley FoolXencor Inc (XNCR) Q1 2021 Earnings Call Transcript - The Motley Fool
fool.com - May 6 at 5:00 PM
Xencor (NASDAQ:XNCR) Posts  Earnings Results, Beats Estimates By $0.72 EPSXencor (NASDAQ:XNCR) Posts Earnings Results, Beats Estimates By $0.72 EPS
americanbankingnews.com - May 6 at 2:20 PM
Wedbush Cuts Xencor (NASDAQ:XNCR) Price Target to $47.00Wedbush Cuts Xencor (NASDAQ:XNCR) Price Target to $47.00
americanbankingnews.com - May 6 at 1:01 PM
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo FinanceXencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
finance.yahoo.com - May 6 at 1:59 AM
Xencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - NasdaqXencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - May 5 at 8:59 PM
Xencor Reports First Quarter 2021 Financial Results - Business WireXencor Reports First Quarter 2021 Financial Results - Business Wire
businesswire.com - May 5 at 8:59 PM
Xencor Reports First Quarter 2021 Financial ResultsXencor Reports First Quarter 2021 Financial Results
finance.yahoo.com - May 5 at 8:59 PM
Xencor (XNCR) Reports Q1 Loss, Tops Revenue EstimatesXencor (XNCR) Reports Q1 Loss, Tops Revenue Estimates
finance.yahoo.com - May 5 at 8:59 PM
(XNCR) - Xencors Earnings: A Preview - Benzinga(XNCR) - Xencor's Earnings: A Preview - Benzinga
benzinga.com - May 4 at 1:03 PM
Akebia highlights late-stage vadadustat kidney disease study results - Seeking AlphaAkebia highlights late-stage vadadustat kidney disease study results - Seeking Alpha
seekingalpha.com - April 30 at 10:44 AM
Xencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021 - Yahoo FinanceXencor to Host First Quarter 2021 Financial Results Webcast and Conference Call on May 5, 2021 - Yahoo Finance
finance.yahoo.com - April 28 at 7:36 PM
Nasdaq Pulls Back Sharply But Dow Holds On To Modest Gain - NasdaqNasdaq Pulls Back Sharply But Dow Holds On To Modest Gain - Nasdaq
nasdaq.com - April 15 at 8:56 AM
XNCR Makes Bullish Cross Above Critical Moving Average - NasdaqXNCR Makes Bullish Cross Above Critical Moving Average - Nasdaq
nasdaq.com - April 14 at 8:08 PM
Health Care Sector Update for 04/14/2021: TECH, GALT, AZN, XLV, IBB - NasdaqHealth Care Sector Update for 04/14/2021: TECH, GALT, AZN, XLV, IBB - Nasdaq
nasdaq.com - April 14 at 10:07 AM
Xencor Presents Positive Data For XmAb Antibodies Program Against Cancer - Yahoo FinanceXencor Presents Positive Data For XmAb Antibodies Program Against Cancer - Yahoo Finance
finance.yahoo.com - April 12 at 4:33 PM
Xencor Presents Positive Data For XmAb Antibodies Program Against CancerXencor Presents Positive Data For XmAb Antibodies Program Against Cancer
finance.yahoo.com - April 12 at 4:33 PM
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021 - Business WireXencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021 - Business Wire
businesswire.com - April 10 at 2:19 PM
Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021Xencor Presents Data from Multiple Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the AACR Annual Meeting 2021
finance.yahoo.com - April 10 at 2:19 PM
INmune Bio, Inc. S-3 Apr. 9, 2021 4:41 PM - Seeking AlphaINmune Bio, Inc. S-3 Apr. 9, 2021 4:41 PM - Seeking Alpha
seekingalpha.com - April 9 at 6:00 PM
Inmune Bio files to sell 1.7M shares from shareholder Xencor - Seeking AlphaInmune Bio files to sell 1.7M shares from shareholder Xencor - Seeking Alpha
seekingalpha.com - April 9 at 6:00 PM
Vir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells - StreetInsider.comVir Biotechnology Announces New Research Demonstrating Novel Mechanisms by Which SARS-CoV-2 Enters Host Cells - StreetInsider.com
streetinsider.com - April 8 at 2:46 PM
Applied BioMath, LLC Launches Software Product for the Early Feasibility Assessment of Biotherapeutics - Yahoo FinanceApplied BioMath, LLC Launches Software Product for the Early Feasibility Assessment of Biotherapeutics - Yahoo Finance
finance.yahoo.com - April 6 at 2:43 PM
Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021 - Business WireXencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021 - Business Wire
businesswire.com - March 10 at 9:02 PM
Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021Xencor to Present Preclinical Data from Four Preclinical XmAb® Bispecific Antibody and Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2021
finance.yahoo.com - March 10 at 9:02 PM
Xencor Inc (XNCR) SR. VICE PRESIDENT & CFO John J Kuch Sold $773,028 of SharesXencor Inc (XNCR) SR. VICE PRESIDENT & CFO John J Kuch Sold $773,028 of Shares
uk.finance.yahoo.com - March 4 at 4:11 AM
Xencor Inc (XNCR) SR. VICE PRESIDENT & CFO John J Kuch Sold $773,028 of Shares - Yahoo FinanceXencor Inc (XNCR) SR. VICE PRESIDENT & CFO John J Kuch Sold $773,028 of Shares - Yahoo Finance
finance.yahoo.com - March 3 at 11:06 PM
Xencor to Present at the Barclays Global Healthcare ConferenceXencor to Present at the Barclays Global Healthcare Conference
finance.yahoo.com - March 3 at 6:05 PM
Xencor Earns RS Rating Upgrade - Investors Business DailyXencor Earns RS Rating Upgrade - Investor's Business Daily
investors.com - March 1 at 3:55 PM
Xencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics - Business WireXencor and UCLA Enter Collaboration to Discover and Develop Novel XmAb® Therapeutics - Business Wire
businesswire.com - February 25 at 2:38 PM
Edited Transcript of XNCR.OQ earnings conference call or presentation 23-Feb-21 9:30pm GMT - Yahoo FinanceEdited Transcript of XNCR.OQ earnings conference call or presentation 23-Feb-21 9:30pm GMT - Yahoo Finance
finance.yahoo.com - February 24 at 8:34 AM
Recap: Xencor Q4 Earnings - Yahoo FinanceRecap: Xencor Q4 Earnings - Yahoo Finance
finance.yahoo.com - February 24 at 8:34 AM
Xencor EPS beats by $0.12, beats on revenue - Seeking AlphaXencor EPS beats by $0.12, beats on revenue - Seeking Alpha
seekingalpha.com - February 24 at 3:34 AM
Xencor Inc (XNCR) Q4 2020 Earnings Call Transcript - Motley FoolXencor Inc (XNCR) Q4 2020 Earnings Call Transcript - Motley Fool
fool.com - February 24 at 3:34 AM
Xencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates - NasdaqXencor (XNCR) Reports Q4 Loss, Tops Revenue Estimates - Nasdaq
nasdaq.com - February 23 at 10:09 PM
Recap: Xencor Q4 EarningsRecap: Xencor Q4 Earnings
finance.yahoo.com - February 23 at 10:09 PM
Xencor Reports Fourth Quarter and Full Year 2020 Financial Results - Business WireXencor Reports Fourth Quarter and Full Year 2020 Financial Results - Business Wire
businesswire.com - February 23 at 5:09 PM
This page was last updated on 5/15/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.